A 53-year-old man with MASLD and F2 fibrosis on elastography, BMI 35, and T2D asks about medications beyond lifestyle changes to reduce disease progre...

Question

A 53-year-old man with MASLD and F2 fibrosis on elastography, BMI 35, and T2D asks about medications beyond lifestyle changes to reduce disease progression. Which of the following aligns with current guidance?

Accepted Answer

Pioglitazone or a GLP-1 receptor agonist may be considered in patients with T2D and MASLD.

Answer

Start long-term prednisone.

Answer

High-dose vitamin C.

Answer

No pharmacologic options exist.

Answer

Start niacin.

us-abim MCQ (SBA): MASLD Pharmacotherapy

A 53-year-old man with MASLD and F2 fibrosis on elastography, BMI 35, and T2D asks about medications beyond lifestyle changes to reduce disease progression. Which of the following aligns with current guidance?